View in EDS

Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report.

Saved in:
Bibliographic Details
Title: Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report.
Authors: Mobayed H; Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar., Al-Nesf MA; Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar., Robles-Velasco K; Respiralab Research Group, Guayaquil, Ecuador.; Universidad Espíritu Santo, Samborondón, Ecuador., Cherrez-Ojeda I; Respiralab Research Group, Guayaquil, Ecuador.; Universidad Espíritu Santo, Samborondón, Ecuador., Ensina LF; Division of Allergy, Immunology, Rheumatology, Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil., Maurer M; GA2LEN Urticaria Center of Reference and Excellence (UACRE), Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Source: Frontiers in allergy [Front Allergy] 2023 Jul 27; Vol. 4, pp. 1228495. Date of Electronic Publication: 2023 Jul 27 (Print Publication: 2023).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918227355906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2673-6101 (Electronic) Linking ISSN: 26736101 NLM ISO Abbreviation: Front Allergy Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37577331
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mobayed+H%22">Mobayed H</searchLink>; Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Al-Nesf+MA%22">Al-Nesf MA</searchLink>; Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Robles-Velasco+K%22">Robles-Velasco K</searchLink>; Respiralab Research Group, Guayaquil, Ecuador.; Universidad Espíritu Santo, Samborondón, Ecuador.<br /><searchLink fieldCode="AU" term="%22Cherrez-Ojeda+I%22">Cherrez-Ojeda I</searchLink>; Respiralab Research Group, Guayaquil, Ecuador.; Universidad Espíritu Santo, Samborondón, Ecuador.<br /><searchLink fieldCode="AU" term="%22Ensina+LF%22">Ensina LF</searchLink>; Division of Allergy, Immunology, Rheumatology, Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Maurer+M%22">Maurer M</searchLink>; GA2LEN Urticaria Center of Reference and Excellence (UACRE), Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918227355906676%22">Frontiers in allergy</searchLink> [Front Allergy] 2023 Jul 27; Vol. 4, pp. 1228495. <i>Date of Electronic Publication: </i>2023 Jul 27 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9918227355906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2673-6101 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226736101%22">26736101 </searchLink><i>NLM ISO Abbreviation: </i>Front Allergy <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37577331
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/falgy.2023.1228495
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1228495
    Titles:
      – TitleFull: Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mobayed H
      – PersonEntity:
          Name:
            NameFull: Al-Nesf MA
      – PersonEntity:
          Name:
            NameFull: Robles-Velasco K
      – PersonEntity:
          Name:
            NameFull: Cherrez-Ojeda I
      – PersonEntity:
          Name:
            NameFull: Ensina LF
      – PersonEntity:
          Name:
            NameFull: Maurer M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 07
              Text: 2023 Jul 27
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2673-6101
          Numbering:
            – Type: volume
              Value: 4
          Titles:
            – TitleFull: Frontiers in allergy
              Type: main
ResultId 1